ID: ALA4792617

Max Phase: Preclinical

Molecular Formula: C38H41F3N3O5P

Molecular Weight: 707.73

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CCOP(=O)(Cc1cccc(COc2ccccc2OC2CCN(Cc3ccc4nc(-c5cccc(C(F)(F)F)c5)[nH]c4c3)CC2)c1)OCC

Standard InChI:  InChI=1S/C38H41F3N3O5P/c1-3-47-50(45,48-4-2)26-29-10-7-9-28(21-29)25-46-35-13-5-6-14-36(35)49-32-17-19-44(20-18-32)24-27-15-16-33-34(22-27)43-37(42-33)30-11-8-12-31(23-30)38(39,40)41/h5-16,21-23,32H,3-4,17-20,24-26H2,1-2H3,(H,42,43)

Standard InChI Key:  YPONQFDDBHJAOJ-UHFFFAOYSA-N

Associated Targets(Human)

Huh-7 12904 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Ebolavirus 617 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 707.73Molecular Weight (Monoisotopic): 707.2736AlogP: 9.64#Rotatable Bonds: 14
Polar Surface Area: 85.91Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: 11.38CX Basic pKa: 8.31CX LogP: 7.69CX LogD: 6.72
Aromatic Rings: 5Heavy Atoms: 50QED Weighted: 0.12Np Likeness Score: -0.93

References

1. Bessières M,Plebanek E,Chatterjee P,Shrivastava-Ranjan P,Flint M,Spiropoulou CF,Warszycki D,Bojarski AJ,Roy V,Agrofoglio LA.  (2021)  Design, synthesis and biological evaluation of 2-substituted-6-[(4-substituted-1-piperidyl)methyl]-1H-benzimidazoles as inhibitors of ebola virus infection.,  214  [PMID:33548632] [10.1016/j.ejmech.2021.113211]

Source